Camylofin
Clinical data | |
---|---|
Other names | Acamylophenine |
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
JSmol) | |
| |
| |
(what is this?) (verify) |
Camylofin is an
antimuscarinic drug.[1]
Camylofin is a
pyrexia.[2]
Synthesis
The Hell–Volhard–Zelinsky halogenation on phenylacetic acid [103-82-2] (1) gives 2-Bromo-2-phenylacetyl bromide, CID:15621041 (2). Treatment with isoamyl alcohol [123-51-3] gives 3-methylbutyl bromo(phenyl)acetate [92018-48-9] (3). Alkylation with N,N-Diethylethylenediamine [100-36-7] (4) completed the synthesis of Camylofin (5).
References
- ^ "Camylofin". PubChem. Retrieved 2019-06-02.
- PMID 24179892.
- ^ Bruzzese, Tiberio; Crescenzi, Elda (1966). "N-Aminoalkyl-α-aminoacids and Their Corresponding Ethyl Esters". Journal of Pharmaceutical Sciences. 55 (7): 737–740. doi:10.1002/jps.2600550717.
- ^ Szarvasi, E. et al, Bull. Soc. Chim. Fr., 1957, 1019.
- ^ Brock Norbert, Kuhas Engelbert, & Schmeisser Martin, U.S. patent 2,665,300 (1954 to Asta Medica AG).
- ^ Martin Dr-Chem Schmeisser, Engelbert Dr Phil Kuehas, Norbert Dr Med Brock, DE842206 (1952 to Asta Werke Ag Chem Fab).
- ^ , GB688331 (1953 to Asta Medica AG).
- ^ , GB782068 (1957 to Asta Medica AG).
- ^ Kuhas Engelbert, Brock Norbert, & Arnold Herbert, CA566251 (1958 to Asta Medica AG).
- ^ Arnold Herbert, Kuhas Engelbert, & Brock Norbert, U.S. patent 2,857,395 (1958).